Elanco.
American healthcare company
- Reports this week
- 2
- Active events
- 2
- Connections
- 84
What's happening
Active this week
-
FDA approved combination clearances for Elanco's Experior use on June 27, 2025.Some support3 reports
-
Accelerated customer purchases in China benefited sales for a company, while Quattro saw increased sell-through in the U.S., coinciding with a comment from William Blair on Elanco's earnings.Some support2 reports
Earlier this month
One to three months ago
-
Elanco is utilizing a manufacturing site in Doniphan County, Kansas, and the expansion is expected to benefit the local county economy.Some support1 report
-
Elanco, a company based in Indianapolis, filed required documents with the SEC on August 19, 2026.Some support1 report
-
Elanco filed required insider trading disclosures with the relevant authorities on August 18, 2026.Some support1 report
Gone quiet
No new reports in 90+ days-
Elanco reported market share gains driven by its successful innovation portfolio within the animal health industry.Some support3 reports
-
CEO Jeffrey N. Simmons purchased Elanco shares, and Norges Bank acquired a new stake in the company, disclosed via SEC filing.Some support1 report
-
Elanco Ventures established a CVC platform in Indianapolis to invest in animal health, leveraging the One Health Innovation District.Some support2 reports
-
Elanco leverages proximity of partnerships in Indianapolis.Some support2 reports
-
Microsoft, Elanco, Monster Beverage, and Jazz Pharmaceuticals were cited in thematic investing as examples of diverse winners in the pharmaceuticals segment.Some support2 reports
-
Elanco was originally a division of Eli Lilly, and Jeff Simmons currently serves as the President and CEO of Elanco.Some support9 reports
-
Trump pledged to unleash American oil and gas production, involving Elanco.Some support1 report
-
Bank of America probed Elanco regarding its innovation revenue guidance on June 30, 2025.Speculative1 report
-
Global license agreement accelerates commercialization of NUZ-001 for neurodegenerative diseases.Speculative1 report
-
Elanco developed a vaccine for canine influenza protection and received approval from the USDA for market release.Speculative2 reports
-
Elanco, Zoetis, and Boehringer Ingelheim are noted for their leadership in the veterinary dermatology market.Some support1 report
-
Elanco and U.S. Physical Therapy were classified as stocks in the Medical Healthcare sector as of July 24, 2025.Some support1 report
-
Elanco secures various market approvals for its product Zenrelia, including availability in the US, EU, Brazil, Canada, and Japan.Some support1 report
-
Wall Street analysts predicted specific quarterly earnings and revenue metrics for Elanco.Some support1 report
-
Elanco's stock performance was compared to the broader market index on August 7, 2025.Some support1 report
-
Elanco attended a conference hosted by Morgan Stanley on August 26, 2025.Some support2 reports
-
Elanco and Splenda announced support for the Nutrition Secure Indianapolis program, marking a specific corporate action in the city.Some support1 report
-
Elanco is joining the S&P MidCap 400 index, Boehringer Ingelheim launched a new swine vaccine, and Sarepta Therapeutics is being replaced in the index.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Elanco this week
News at the entities that move Elanco most-
Eli Lilly and Company StructuralEli Lilly and Company is utilizing major wholesale distribution partners, including Cardinal Health and McKesson Corp, in its operational structure.Moves Elanco
-
SEC StructuralDHS leans on AbbVie, Altria, and Merck for stock weighting, while the SEC legally requires fiduciaries to prioritize client interests.Moves Elanco
-
FDA StructuralDBV Technologies is seeking regulatory acceptance for its product from the FDA.Moves Elanco
-
Goldman Sachs TransactionalLPL cited trading data from Morgan Stanley and Goldman Sachs regarding major technology companies.Moves Elanco
-
Jazz Pharmaceuticals OperationalTD Cowen boosted its price target and gave a buy rating for Jazz Pharmaceuticals.Moves Elanco
-
Purdue University OperationalJay B. Silveria has been named the 14th president of Purdue University.Moves Elanco
Connections
The 22 strongest of 84, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Eli Lilly and Company Structural
Elanco was historically established as a division and subsidiary of Eli Lilly and Company.
-
Jeffrey N. Simmons Structural
Jeffrey N. Simmons serves as the CEO of Elanco.
-
Jeff Simmons Structural
Jeff Simmons holds the executive leadership role of CEO and President at Elanco.
-
SEC Structural
Elanco is subject to mandatory disclosure and regulatory oversight by the SEC.
-
FDA Structural
The FDA provides necessary regulatory oversight and approvals for Elanco's products and market operations.
-
Zoetis Operational
Elanco and Zoetis are direct competitors operating in the animal health and veterinary dermatology markets.
-
Center for Veterinary Medicine Structural
Elanco relies on the Center for Veterinary Medicine for the review of its drug applications.
-
Jazz Pharmaceuticals Operational
The two companies actively compete and operate within the specialized pharmaceutical market segment.
Show all 22 connections
-
Todd Young Operational
Todd Young served as an advisor and CFO for Elanco, managing cost control.
-
Kelso Transactional
Elanco sponsors the Kelso Ram Sales event.
-
Norges Bank Transactional
Norges Bank acquired a new stake in Elanco.
-
Lancaster County Shared context
The relationship is defined by a shared local context through involvement in the Library Board of Trustees in Lancaster County.
-
Monster Beverage Mentioned together
The entities are co-mentioned in articles grouping them thematically as diverse growth stocks and winners.
-
Doniphan County Shared context
Elanco's expansion provides economic benefits to Doniphan County.
-
Indianapolis Shared context
Elanco is based in Indianapolis and actively participates in local innovation and health programs.
-
Buy Shared context
Elanco conducts business operations within the location of Buy, as required for insider trading disclosures.
-
Kansas Shared context
Elanco utilizes a manufacturing site located within the state of Kansas.
-
Goldman Sachs Transactional
Goldman Sachs initiated a buy recommendation/investment on Elanco.
-
Indiana Shared context
Elanco is an Indiana-based company operating within a state known for its health sector expertise.
-
Purdue University Operational
Both Purdue University and Elanco anchor the One Health Research Institute.
-
Texas Shared context
Elanco operates within the agricultural context of Texas, where livestock health issues occur.
-
Centers for Disease Control Mentioned together
The provided evidence does not describe any relationship or coupling between the Centers for Disease Control and Elanco.
History
Events by the month they beganOctober 2026
2 eventsAugust 2026
4 events- Elanco is utilizing a manufacturing site in Doniphan County, Kansas, and the expansion is expected to benefit the local county economy.
- Elanco, a company based in Indianapolis, filed required documents with the SEC on August 19, 2026.
- Elanco filed required insider trading disclosures with the relevant authorities on August 18, 2026.
- Elanco reported market share gains driven by its successful innovation portfolio within the animal health industry.
July 2026
1 eventShow 1 earlier month
June 2026
18 events- FDA approved combination clearances for Elanco's Experior use on June 27, 2025.
- Accelerated customer purchases in China benefited sales for a company, while Quattro saw increased sell-through in the U.S., coinciding with a comment from William Blair on Elanco's earnings.
- Elanco Ventures established a CVC platform in Indianapolis to invest in animal health, leveraging the One Health Innovation District.
- Elanco leverages proximity of partnerships in Indianapolis.
- Microsoft, Elanco, Monster Beverage, and Jazz Pharmaceuticals were cited in thematic investing as examples of diverse winners in the pharmaceuticals segment.
- Elanco was originally a division of Eli Lilly, and Jeff Simmons currently serves as the President and CEO of Elanco.
- Trump pledged to unleash American oil and gas production, involving Elanco.
- Bank of America probed Elanco regarding its innovation revenue guidance on June 30, 2025.
- Global license agreement accelerates commercialization of NUZ-001 for neurodegenerative diseases.
- Elanco developed a vaccine for canine influenza protection and received approval from the USDA for market release.
- Elanco, Zoetis, and Boehringer Ingelheim are noted for their leadership in the veterinary dermatology market.
- Elanco and U.S. Physical Therapy were classified as stocks in the Medical Healthcare sector as of July 24, 2025.
- Elanco secures various market approvals for its product Zenrelia, including availability in the US, EU, Brazil, Canada, and Japan.
- Wall Street analysts predicted specific quarterly earnings and revenue metrics for Elanco.
- Elanco's stock performance was compared to the broader market index on August 7, 2025.
- Elanco attended a conference hosted by Morgan Stanley on August 26, 2025.
- Elanco and Splenda announced support for the Nutrition Secure Indianapolis program, marking a specific corporate action in the city.
- Elanco is joining the S&P MidCap 400 index, Boehringer Ingelheim launched a new swine vaccine, and Sarepta Therapeutics is being replaced in the index.